SCHEMBL16736745

SCHEMBL16736745

CCCCc1cc(Cl)c(CCCC)cc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 3/20 0.53
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
HTT P42858 4/20 0.46
TDP1 Q9NUW8 4/20 0.46
MAPT P10636 4/20 0.46
ALOX15 P16050 3/20 0.46
CYP3A4 P08684 2/20 0.46
TP53 P04637 1/20 0.46
ALOX5 P09917 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 4/20 0.42
HPGD P15428 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ALOX12 P18054 1/20 0.41
HMGCR P04035 1/20 0.40
RECQL P46063 3/20 0.38
THRB P10828 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16736725 0.96 TYR (0.50) TYRMEN1KMT2AHTTTDP1
SCHEMBL16736776 0.96 TYR (0.50) TYRMEN1KMT2AHTTTDP1
SCHEMBL16736895 0.92 TYR (0.50) TYRMEN1KMT2AHTTTDP1
SCHEMBL16736915 0.92 TYR (0.50) TYRMEN1KMT2AHTTTDP1
SCHEMBL68685 0.88 TYR (0.53) TYRMEN1KMT2AHTTTDP1
SCHEMBL16736863 0.88 HMGCR (0.52) TYRMEN1KMT2AHTTTDP1
SCHEMBL156399 0.87 TYR (0.65) TYRMEN1KMT2AHTTTDP1
SCHEMBL8359245 0.87 CTRC (0.44) TYRMEN1KMT2AHTTTDP1
SCHEMBL16736891 0.85 TYR (0.50) TYRMEN1KMT2AHTTTDP1
SCHEMBL16736813 0.85 TYR (0.46) TYRMEN1KMT2AHTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170174600-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS TANSNA THERAPEUTICS, INC. 2017-06-22 US disclosed
US-20170174600-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS TANSNA THERAPEUTICS, INC. 2017-06-22 US disclosed
US-9630896-B2 2,5-dialkyl-4-H/halo/ether-phenol compounds TANSNA THERAPEUTICS, INC. (US) 2017-04-25 US disclosed
US-9630896-B2 2,5-dialkyl-4-H/halo/ether-phenol compounds TANSNA THERAPEUTICS, INC. (US) 2017-04-25 US disclosed
US-9630896-B2 2,5-dialkyl-4-H/halo/ether-phenol compounds TANSNA THERAPEUTICS, INC. (US) 2017-04-25 US disclosed
US-20150148430-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS TANSNA THERAPEUTICS, INC. 2015-05-28 US disclosed
US-20150148430-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS TANSNA THERAPEUTICS, INC. 2015-05-28 US disclosed
US-20150148430-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS TANSNA THERAPEUTICS, INC. 2015-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170174600-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS COMT, DDT, TYR TYR 3/4885MEN1 4009/4885KMT2A 606/4885
US-20150148430-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS COMT, DDT, TYR TYR 3/4885MEN1 4009/4885KMT2A 606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.